Response to Maccio et al, “Multifactorial pathogenesis of COVID‐19‐related coagulopathy: Can defibrotide have a role in the early phases of coagulation disorders?”

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of thrombosis and haemostasis 2020-11, Vol.18 (11), p.3111-3113
Hauptverfasser:	Richardson, Edward, Carlo‐Stella, Carmelo, Jara, Ruben, Vlodavsky, Israel, Iacobelli, Massimo, Fareed, Jawed, Mo, Clifton, O'Gorman, Peter, Yanik, Gregory, Palomo, Marta, Diaz‐Ricart, Maribel, Moraleda, Jose M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Blood Coagulation Disorders - drug therapy Blood Coagulation Disorders - virology Cardiovascular System & Cardiology COVID-19 COVID-19 - complications defibrotide Hematology heparanase Humans Letter to the Editor Life Sciences & Biomedicine p38 mitogen‐activated protein kinases Pandemics Peripheral Vascular Disease Polydeoxyribonucleotides - therapeutic use SARS-CoV-2 Science & Technology thrombosis Vascular Endothelium
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!